Xenetic Biosciences Inc (XBIO)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	74.09% 1.027	0.5899	0.5933	0.6488	0.6142
Operating Expenses	19.58% 1.5717	1.3143	1.5357	1.748	1.1137
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	19.58% 1.5717	1.3143	1.5357	1.748	1.1137
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	24.80% -0.5447	-0.7244	-0.9424	-1.0991	-0.4995
Net Interest Income/Expense	10.08% 0.0308	0.0342	0.0392	0.0519	0.0613
Nonoperating Income/Loss	2.56% 0.0348	0.0357	0.0393	0.0446	0.0628
Income/Loss From Continuing Operations Before Tax	74.09% 1.027	0.5899	0.5933	0.6488	0.6142
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	25.96% -0.5099	-0.6887	-0.9031	-1.0545	-0.4367
Net Income/Loss	25.96% -0.5099	-0.6887	-0.9031	-1.0545	-0.4367
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 1.5421	1.5421	1.5421	0.000269	1.5417
Diluted Average Shares	0.00% 1.5421	1.5421	1.5421	0.000269	1.5417
Basic Earnings Per Share	26.67% -0.33	-0.45	-0.59	-0.68	-0.28
Diluted Earnings Per Share	26.67% -0.33	-0.45	-0.59	-0.68	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%